ID

15343

Descripción

Principal Investigator: Luisa Klotz Collaborator: Novartis Information provided by (Responsible Party):University Hospital Muenster -Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya (ToFingo2) Purpose A trial in patients with relapsing remitting multiple sclerosis (RRMS) Main objectives: •To evaluate changes in the reconstitution of immune surveillance over time upon switching from natalizumab to fingolimod assessed by a change in the expression of CD49d. •To evaluate changes in the migratory capacity of immune cells/peripheral blood mononuclear cells (PBMCs) upon switching from natalizumab to fingolimod in an in-vitro model of the blood-brain-barrier (BBB). •To evaluate changes in paraclinical disease activity over time upon switching from natalizumab to fingolimod assessed by MRI (changes in Gd+, T2w lesions and DTI). •To evaluate changes in T1w / FLAIR lesions upon switching from natalizumab to fingolimod. For further Information please visit https://clinicaltrials.gov/ct2/show/NCT02325440

Link

https://clinicaltrials.gov/ct2/show/NCT02325440

Palabras clave

Versiones (3)
  1. 27/5/16 27/5/16 -
  2. 31/5/16 31/5/16 -
  3. 31/5/16 31/5/16 -
Subido en

27 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

ToFingo Screening V1 Pre-examination NCT02325440

Inglés

ToFingo Screening V1 Pre-examination NCT02325440

1 formularios  
Other
Descripción

Other

Alias
UMLS CUI-1
C0205394
Data entry for this CRF completed
Descripción

Data entry for this CRF completed

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3899518
Assessment date
Descripción

Assessment Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0011008
Current patient (ID)
Descripción

Current patient (ID)

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
MSFC (Multiple Sclerosis Functional Composite Measure)
Descripción

MSFC (Multiple Sclerosis Functional Composite Measure)

Alias
UMLS CUI-1
C0026769
UMLS CUI-2
C0449820
Endscore
Descripción

Endscore

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C0449820
Last natalizumab dose
Descripción

Last natalizumab dose

Alias
UMLS CUI-1
C1762893
UMLS CUI-2
C1172734
Last natalizumab dose taken (300mg)
Descripción

Last natalizumab dose taken (300mg)

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1762893
UMLS CUI [1,2]
C1172734
Ophthalmologic examination
Descripción

Ophthalmologic examination

Alias
UMLS CUI-1
C0200149
Opthalmologic examination: Result
Descripción

Opthalmologic examination: Result

Tipo de datos

text

Alias
UMLS CUI [1]
C0200149
Opthalmologic examination: Comment
Descripción

Opthalmologic examination: Comment

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0200149
UMLS CUI [1,2]
C0947611
History of uveitis or diabetes mellitus: Result
Descripción

History of uveitis or diabetes melitus: Result

Tipo de datos

text

Alias
UMLS CUI [1]
C0042164|C0011849
History of uveitis or diabetes mellitus: Comment
Descripción

History of uveitis or diabetes mellitus: Comment

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0042164|C0011849
UMLS CUI [1,2]
C0947611
Abnormalities: Result
Descripción

Abnormalities: Result

Tipo de datos

text

Alias
UMLS CUI [1]
C1704258
Abnormalities: Comment
Descripción

Abnormalities: Comment

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1704258
UMLS CUI [1,2]
C0947611
Volver a la parte superior de la página

Similar models

ToFingo Screening V1 Pre-examination NCT02325440

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Other
C0205394 (UMLS CUI-1)
Data entry for this CRF completed
Item
Data entry for this CRF completed
boolean
C3899518 (UMLS CUI [1])
Assessment Date
Item
Assessment date
date
C0011008 (UMLS CUI [1])
Current patient (ID)
Item
Current patient (ID)
text
C2348585 (UMLS CUI [1])
Item Group
MSFC (Multiple Sclerosis Functional Composite Measure)
C0026769 (UMLS CUI-1)
C0449820 (UMLS CUI-2)
Endscore
Item
Endscore
integer
C0026769 (UMLS CUI [1,1])
C0449820 (UMLS CUI [1,2])
Item Group
Last natalizumab dose
C1762893 (UMLS CUI-1)
C1172734 (UMLS CUI-2)
Last natalizumab dose taken (300mg)
Item
Last natalizumab dose taken (300mg)
date
C1762893 (UMLS CUI [1,1])
C1172734 (UMLS CUI [1,2])
Item Group
Ophthalmologic examination
C0200149 (UMLS CUI-1)
Opthalmologic examination: Result
Item
Opthalmologic examination: Result
text
C0200149 (UMLS CUI [1])
Opthalmologic examination: Comment
Item
Opthalmologic examination: Comment
text
C0200149 (UMLS CUI [1,1])
C0947611 (UMLS CUI [1,2])
History of uveitis or diabetes melitus: Result
Item
History of uveitis or diabetes mellitus: Result
text
C0042164|C0011849 (UMLS CUI [1])
History of uveitis or diabetes mellitus: Comment
Item
History of uveitis or diabetes mellitus: Comment
text
C0042164|C0011849 (UMLS CUI [1,1])
C0947611 (UMLS CUI [1,2])
Abnormalities: Result
Item
Abnormalities: Result
text
C1704258 (UMLS CUI [1])
Abnormalities: Comment
Item
Abnormalities: Comment
text
C1704258 (UMLS CUI [1,1])
C0947611 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial